Viewing Study NCT00022360


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-02-02 @ 9:19 AM
Study NCT ID: NCT00022360
Status: COMPLETED
Last Update Posted: 2013-06-18
First Post: 2001-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Taurolidine in Treating Patients With Recurrent or Progressive Glioma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult brain tumor View
None adult glioblastoma View
None adult anaplastic astrocytoma View
None adult giant cell glioblastoma View
None adult gliosarcoma View